Moreover, genetic amplification or mutational up-regulation of E6AP is associated with autism-spectrum disorders, and deletion or down-regulation of this ligase in the brain results in a neurodevelopmental disease known as Angelman's syndrome (45, 46). This evidence concerns the gene UBE3A and Angelman syndrome.